Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Sep;132(4):640-653.
doi: 10.1002/jso.70055. Epub 2025 Jul 29.

Surgery in Ovarian Cancer-Brazilian Society of Surgical Oncology Consensus

Affiliations
Review

Surgery in Ovarian Cancer-Brazilian Society of Surgical Oncology Consensus

Audrey Tieko Tsunoda et al. J Surg Oncol. 2025 Sep.

Abstract

Surgical management in epithelial ovarian cancer (EOC) has a significant impact on overall survival (OS) and progression-free survival (PFS). The Brazilian Society of Surgical Oncology (BSSO) supported an expert-led task force for consensus: the best EOC surgery is provided by experienced and specialized trained surgeons in cancer centers. Laparoscopic or radiological staging can predict the possibility of complete cytoreduction (CC0) and help to reduce unnecessary laparotomies. Carcinomatosis and nodal extension should be evaluated at imaging. Multidisciplinary input is essential for determining the need for the selection of patients for surgery and adjuvant chemotherapy in patients with EOC. The BSSO proposes quality assurance criteria and the need for national consensus. Genetic counseling was deemed mandatory for all patients with EOC. This consensus states the final recommendations from BSSO for the management of EOC.

Keywords: Brazilian Society of Surgical Oncology; consensus; epithelial ovarian cancer; surgery.

PubMed Disclaimer

Conflict of interest statement

The authors do not have relevant financial, personal, political, intellectual, or religious interests. Audrey Tieko Tsunoda received honorary for educational lectures and/or advisory board activities for Roche, AstraZeneca, MSD, GSK, and Johnson & Johnson. Renato Moretti‐Marques received honorary for educational lectures for Roche and AstraZeneca. Reitan Ribeiro received honorary for educational lectures and material development, and consulting from Roche, and educational lectures from Johnson & Johnson, GSK, MSD, and AstraZeneca. Carlos Eduardo Mattos da Cunha Andrade received honorary for educational lectures and material development from AstraZeneca, without competing interests with this study.

References

    1. Galvan‐Turner V. B., Chang J., Ziogas A., and Bristow R. E., “Observed‐to‐Expected Ratio for Adherence to Treatment Guidelines as a Quality of Care Indicator for Ovarian Cancer,” Gynecologic Oncology 139, no. 3 (2015): 495–499, 10.1016/j.ygyno.2015.09.015. - DOI - PMC - PubMed
    1. Al Rawahi T., Lopes A. D., Bristow R. E., et al., “Surgical Cytoreduction for Recurrent Epithelial Ovarian Cancer,” Cochrane Database of Systematic Reviews 2013, no. 2 (2013): CD008765, 10.1002/14651858.CD008765.pub3. - DOI - PMC - PubMed
    1. Mayor S., “WHO Priority List of Medical Devices for Cancer Management,” Lancet Oncology 18, no. 7 (2017): 856, 10.1016/S1470-2045(17)30407-2. - DOI - PubMed
    1. R. J. Morgan, Jr. , Armstrong D. K., Alvarez R. D., et al., “Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology,” Journal of the National Comprehensive Cancer Network 14, no. 9 (2016): 1134–1163, 10.6004/jnccn.2016.0122. - DOI - PubMed
    1. Bray F., Laversanne M., Sung H., et al., “Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,” CA: A Cancer Journal for Clinicians 74, no. 3 (2024): 229–263, 10.3322/caac.21834. - DOI - PubMed